Cassianne Robinson-Cohen1, Traci M Bartz2, Dongbing Lai3, T Alp Ikizler4, Munro Peacock5, Erik A Imel5, Erin D Michos6, Tatiana M Foroud3, Kristina Akesson7,8, Kent D Taylor9, Linnea Malmgren7,8, Kunihiro Matsushita6,10,11, Maria Nethander12, Joel Eriksson13, Claes Ohlsson13, Daniel Mellström13, Myles Wolf14, Osten Ljunggren15, Fiona McGuigan7,8, Jerome I Rotter9, Magnus Karlsson7,8, Michael J Econs3,5, Joachim H Ix16,17, Pamela L Lutsey18, Bruce M Psaty19,20, Ian H de Boer21, Bryan R Kestenbaum21. 1. Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; cassianne.robinson-cohen@vumc.org. 2. Cardiovascular Health Research Unit, Departments of Biostatistics and Medicine. 3. Departments of Medical and Molecular Genetics and. 4. Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 5. Medicine, Indiana University, Indianapolis, Indiana. 6. Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, Maryland. 7. Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Science Malmö, Lund University, Malmö, Sweden. 8. Department of Orthopaedics, Skåne University Hospital, Malmö, Sweden. 9. The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles Medical Center, Torrance, California. 10. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and. 11. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland. 12. Department of Medicine, Bioinformatics Core Facility and. 13. Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 14. Division of Nephrology, Department of Medicine, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. 15. Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University, Uppsala, Sweden. 16. Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, California. 17. Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, California. 18. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota. 19. Cardiovascular Health Research Unit, Departments of Epidemiology, Health Services and Medicine, and. 20. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 21. Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.
Abstract
BACKGROUND: Fibroblast growth factor 23 (FGF23), a bone-derived hormone that regulates phosphorus and vitamin D metabolism, contributes to the pathogenesis of mineral and bone disorders in CKD and is an emerging cardiovascular risk factor. Central elements of FGF23 regulation remain incompletely understood; genetic variation may help explain interindividual differences. METHODS: We performed a meta-analysis of genome-wide association studies of circulating FGF23 concentrations among 16,624 participants of European ancestry from seven cohort studies, excluding participants with eGFR<30 ml/min per 1.73 m2 to focus on FGF23 under normal conditions. We evaluated the association of single-nucleotide polymorphisms (SNPs) with natural log-transformed FGF23 concentration, adjusted for age, sex, study site, and principal components of ancestry. A second model additionally adjusted for BMI and eGFR. RESULTS: We discovered 154 SNPs from five independent regions associated with FGF23 concentration. The SNP with the strongest association, rs17216707 (P=3.0×10-24), lies upstream of CYP24A1, which encodes the primary catabolic enzyme for 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Each additional copy of the T allele at this locus is associated with 5% higher FGF23 concentration. Another locus strongly associated with variations in FGF23 concentration is rs11741640, within RGS14 and upstream of SLC34A1 (a gene involved in renal phosphate transport). Additional adjustment for BMI and eGFR did not materially alter the magnitude of these associations. Another top locus (within ABO, the ABO blood group transferase gene) was no longer statistically significant at the genome-wide level. CONCLUSIONS: Common genetic variants located near genes involved in vitamin D metabolism and renal phosphate transport are associated with differences in circulating FGF23 concentrations.
BACKGROUND:Fibroblast growth factor 23 (FGF23), a bone-derived hormone that regulates phosphorus and vitamin D metabolism, contributes to the pathogenesis of mineral and bone disorders in CKD and is an emerging cardiovascular risk factor. Central elements of FGF23 regulation remain incompletely understood; genetic variation may help explain interindividual differences. METHODS: We performed a meta-analysis of genome-wide association studies of circulating FGF23 concentrations among 16,624 participants of European ancestry from seven cohort studies, excluding participants with eGFR<30 ml/min per 1.73 m2 to focus on FGF23 under normal conditions. We evaluated the association of single-nucleotide polymorphisms (SNPs) with natural log-transformed FGF23 concentration, adjusted for age, sex, study site, and principal components of ancestry. A second model additionally adjusted for BMI and eGFR. RESULTS: We discovered 154 SNPs from five independent regions associated with FGF23 concentration. The SNP with the strongest association, rs17216707 (P=3.0×10-24), lies upstream of CYP24A1, which encodes the primary catabolic enzyme for 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Each additional copy of the T allele at this locus is associated with 5% higher FGF23 concentration. Another locus strongly associated with variations in FGF23 concentration is rs11741640, within RGS14 and upstream of SLC34A1 (a gene involved in renal phosphate transport). Additional adjustment for BMI and eGFR did not materially alter the magnitude of these associations. Another top locus (within ABO, the ABO blood group transferase gene) was no longer statistically significant at the genome-wide level. CONCLUSIONS: Common genetic variants located near genes involved in vitamin D metabolism and renal phosphate transport are associated with differences in circulating FGF23 concentrations.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Tobias Larsson; Xijie Yu; Siobhan I Davis; Mohamad S Draman; Sean D Mooney; Michael J Cullen; Kenneth E White Journal: J Clin Endocrinol Metab Date: 2005-02-01 Impact factor: 5.958
Authors: Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson Journal: J Bone Miner Res Date: 2006-04-05 Impact factor: 6.741
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Andreas S Rigas; Adam A Berkfors; Ole B Pedersen; Erik Sørensen; Kaspar R Nielsen; Margit H Larsen; Helene M Paarup; Hans H Wandall; Christian Erikstrup; Henrik Hjalgrim; Henrik Ullum Journal: Transfusion Date: 2017-10-08 Impact factor: 3.157
Authors: Bryan Kestenbaum; Michael C Sachs; Andy N Hoofnagle; David S Siscovick; Joachim H Ix; Cassianne Robinson-Cohen; Joao A C Lima; Joseph F Polak; Marc Blondon; John Ruzinski; Denise Rock; Ian H de Boer Journal: Circ Heart Fail Date: 2014-03-25 Impact factor: 8.790
Authors: Nicholas L Smith; Ming-Huei Chen; Abbas Dehghan; David P Strachan; Saonli Basu; Nicole Soranzo; Caroline Hayward; Igor Rudan; Maria Sabater-Lleal; Joshua C Bis; Moniek P M de Maat; Ann Rumley; Xiaoxiao Kong; Qiong Yang; Frances M K Williams; Veronique Vitart; Harry Campbell; Anders Mälarstig; Kerri L Wiggins; Cornelia M Van Duijn; Wendy L McArdle; James S Pankow; Andrew D Johnson; Angela Silveira; Barbara McKnight; Andre G Uitterlinden; Nena Aleksic; James B Meigs; Annette Peters; Wolfgang Koenig; Mary Cushman; Sekar Kathiresan; Jerome I Rotter; Edwin G Bovill; Albert Hofman; Eric Boerwinkle; Geoffrey H Tofler; John F Peden; Bruce M Psaty; Frank Leebeek; Aaron R Folsom; Martin G Larson; Timothy D Spector; Alan F Wright; James F Wilson; Anders Hamsten; Thomas Lumley; Jacqueline C M Witteman; Weihong Tang; Christopher J O'Donnell Journal: Circulation Date: 2010-03-15 Impact factor: 29.690
Authors: Elvis Akwo; Mindy M Pike; Lale A Ertuglu; Nicholas Vartanian; Eric Farber-Eger; Loren Lipworth; Farzana Perwad; Edward Siew; Adriana Hung; Nisha Bansal; Ian de Boer; Bryan Kestenbaum; Nancy J Cox; T Alp Ikizler; Quinn Wells; Cassianne Robinson-Cohen Journal: Clin J Am Soc Nephrol Date: 2022-07-28 Impact factor: 10.614
Authors: Marciana L Laster; Bryce Rowan; Hua-Chang Chen; Tae-Hwi Schwantes-An; Xin Sheng; Peter A Friedman; T Alp Ikizler; Janet S Sinshiemer; Joachim H Ix; Katalin Susztak; Ian H de Boer; Bryan Kestenbaum; Adriana Hung; Sharon M Moe; Farzana Perwad; Cassianne Robinson-Cohen Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134
Authors: Tae-Hwi Schwantes-An; Sai Liu; Margaret Stedman; Brian S Decker; Leah Wetherill; Howard J Edenberg; Matteo Vatta; Tatiana M Foroud; Glenn M Chertow; Sharon M Moe Journal: Am J Nephrol Date: 2019-01-22 Impact factor: 3.754
Authors: Erin B Ware; Jennifer A Smith; Wei Zhao; Ron T Ganesvoort; Gary C Curhan; Martin Pollak; David B Mount; Stephen T Turner; Guotao Chen; Ronak Jagdeep Shah; Sharon L R Kardia; John C Lieske Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2019-11-22
Authors: Nicholas H Harbin; Sara N Bramlett; Carolina Montanez-Miranda; Gizem Terzioglu; John R Hepler Journal: Int J Mol Sci Date: 2021-06-25 Impact factor: 5.923